Gene · 6613
NIH grants1,341
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,341
Download this page as JSON| Grant | Title | SUMO2 papers | Newest fiscal year |
|---|---|---|---|
| R35CA197623 | Targeting intratumor heterogeneity in breast cancer | 1 | 2025 |
| R35CA210098 | Overcoming resistance to anti-PD1 immunotherapy | 1 | 2025 |
| R35CA274234 | Exploring DNA damage response pathways as targets for cancer therapy | 1 | 2025 |
| R35GM118080 | Structural studies of RNA processing and ubiquitin-like protein modification | 1 | 2025 |
| R35GM118091 | Quantitative, Mechanistic Studies of Biomolecular Recognition | 1 | 2025 |
| R35GM118093 | Structural and functional studies of mRNA processing, stability and quality control | 1 | 2025 |
| R35GM118136 | Regulation of mRNA processing: Mechanisms and Consequences | 1 | 2025 |
| R35GM119537 | Mechanical forces in nanoscale biology: From hemostasis to single-molecule centrifugation | 1 | 2025 |
| R35GM119840 | Chemical biology approaches to probe signaling by protein lipidation | 1 | 2025 |
| R35GM127073 | Role of the integral membrane protease ZMPSTE24 in membrane protein biogenesis and virus-host cell fusion | 1 | 2025 |
| R35GM128625 | Structure and Function of Immune Gene Regulatory Networks | 1 | 2025 |
| R35GM130367 | Multi-scaled Modeling of Electrostatic and Polarization Effects in Biomolecules | 1 | 2025 |
| R35GM130393 | Mechanistic studies of chromatin modification in transcription regulation | 1 | 2025 |
| R35GM134918 | Mapping transient interactions with and on genomic DNA | 1 | 2025 |
| R35GM136325 | Mechanisms of Cell Regulation and Manipulation by the Ubiquitin System | 1 | 2025 |
| R35GM136421 | Robust ultra-high sensitivity proteomic technologies for limited samples | 1 | 2025 |
| R35GM138003 | Understanding How Metabolic Cofactors Control Cell Function and Fate | 1 | 2025 |
| R35GM139610 | Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis | 1 | 2025 |
| R35GM141736 | Cell Organization Through Phase Separation: Mechanisms, Functions and Disease | 1 | 2025 |
| R35GM142527 | Mechanisms of eIF3-mediated translation regulation | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/grants?page=9